156 related articles for article (PubMed ID: 35945708)
21. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
22. [Malignant mucosal melanomas of the head and neck--collective review from six cancer hospitals].
Omura K; Takemiya S; Shimada F; Shimada A; Ono I; Uchida M; Tanigawa Y; Matsuura S; Takeoda K
Gan No Rinsho; 1986 Oct; 32(12):1511-8. PubMed ID: 3783975
[TBL] [Abstract][Full Text] [Related]
23. Current studies of immunotherapy in head and neck cancer.
Dogan V; Rieckmann T; Münscher A; Busch CJ
Clin Otolaryngol; 2018 Feb; 43(1):13-21. PubMed ID: 28464441
[TBL] [Abstract][Full Text] [Related]
24. Mucosal melanoma of the head and neck: a systematic review of the literature.
Lazarev S; Gupta V; Hu K; Harrison LB; Bakst R
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1108-18. PubMed ID: 25539369
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant immunotherapy for patients with melanoma: are patients with melanoma of the head and neck candidates for this therapy?
Shaw PM; Sivanandham M; Bernik SF; Ditaranto K; Wallack MK
Head Neck; 1997 Oct; 19(7):595-603. PubMed ID: 9323148
[TBL] [Abstract][Full Text] [Related]
26. Mucosal melanoma of the head and neck: 32-year experience in a tertiary referral hospital.
Chan RC; Chan JY; Wei WI
Laryngoscope; 2012 Dec; 122(12):2749-53. PubMed ID: 23161468
[TBL] [Abstract][Full Text] [Related]
27. Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review.
Amin N; Maroun CA; El Asmar M; Alkhatib HH; Guller M; Herberg ME; Zhu G; Seiwert TY; Pardoll D; Eisele DW; Fakhry C; Gourin CG; Mandal R
Head Neck; 2022 Feb; 44(2):562-571. PubMed ID: 34825751
[TBL] [Abstract][Full Text] [Related]
28. [Clinical characteristic and prognostic analyses of 117 cases of head and neck mucosal melanoma].
Yin GF; Guo W; Chen XH; Liu ZY; Huang ZG
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):668-674. PubMed ID: 30293258
[No Abstract] [Full Text] [Related]
29. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant Therapy and Prognosticators of Survival in Head and Neck Mucosal Melanoma.
Abiri A; Yasaka TM; Lehrich BM; Goshtasbi K; Papagiannopoulos P; Tajudeen BA; St John MA; Harris JP; Kuan EC
Laryngoscope; 2022 Mar; 132(3):584-592. PubMed ID: 34355791
[TBL] [Abstract][Full Text] [Related]
31. Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013.
Plavc G; But-Hadžić J; Aničin A; Lanišnik B; Didanović V; Strojan P
Radiat Oncol; 2016 Oct; 11(1):137. PubMed ID: 27737700
[TBL] [Abstract][Full Text] [Related]
32. Mucosal melanoma of the head and neck.
Stern SJ; Guillamondegui OM
Head Neck; 1991; 13(1):22-7. PubMed ID: 1989926
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment outcomes and prognosis of mucosal melanoma of the head and neck: 161 cases from a single institution.
Sun S; Huang X; Gao L; Zhang Y; Luo J; Zhang S; Wang K; Qu Y; Wu R; Liu Q; Xiao J; Xu G; Yi J
Oral Oncol; 2017 Nov; 74():115-122. PubMed ID: 29103739
[TBL] [Abstract][Full Text] [Related]
34. Improved Survival with Immunotherapy but Lack of Synergistic Effect with Radiation for Stage IV Melanoma of the Head and Neck.
Babcock B; Rodrigues M; Kearns D; Solomon N; Reeves ME; Senthil M; Garberoglio CA; Namm JP
Am Surg; 2019 Oct; 85(10):1118-1124. PubMed ID: 31657306
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
[TBL] [Abstract][Full Text] [Related]
36. Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.
Sasse AD; Sasse EC; Clark LG; Ulloa L; Clark OA
Cochrane Database Syst Rev; 2007 Jan; (1):CD005413. PubMed ID: 17253556
[TBL] [Abstract][Full Text] [Related]
37. Management of Head and Neck Mucosal Melanoma.
Nenclares P; Harrington KJ
Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):299-314. PubMed ID: 35400572
[TBL] [Abstract][Full Text] [Related]
38. [Clinical analysis of 16 cases of malignant head and neck melanoma].
Ryuto M; Higaki Y; Tomita K
Nihon Jibiinkoka Gakkai Kaiho; 2001 Sep; 104(9):859-65. PubMed ID: 11605226
[TBL] [Abstract][Full Text] [Related]
39. [Head and neck cancer : promising results of immunotherapy].
Sivade A; Bensaid D; Monnier Y; Shabafrouz K; Bouchaab H; Cristina V
Rev Med Suisse; 2017 May; 13(563):1029-1031. PubMed ID: 28636292
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
